MetaCap

Heartflow Quarterly Cash Flow Statement

NASDAQ: HTFLHealth CareMedical/Dental InstrumentsUSD

49.74+2.11 (+4.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Heartflow free cash flow

In the quarter ended Jun 30, 2026, Heartflow generated -$8.6 million of operating cash flow and spent $1.9 million on capital expenditures. That left free cash flow of -$10.5 million, a free-cash-flow margin of -16.4% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

Heartflow cash flow statement (quarterly)

Heartflow quarterly cash flow statement
Quarter (USD)Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31
Net Income-15.74M-27.38M-24.39M-50.85M-9.20M-32.34M-32.98M-19.14M-23.38M-20.93M
Net Income growth (YoY)——————————
Depreciation & Amortization1.22M1.42M1.37M1.30M1.40M1.37M1.59M1.39M——
Stock-Based Compensation7.91M6.55M5.26M3.96M2.25M2.49M2.51M2.34M2.64M—
Change in Working Capital-7.83M-8.43M-6.02M2.13M-3.09M-5.64M396.00K369.00K——
Operating Cash Flow-8.58M-30.10M-10.60M-2.96M-27.30M-13.17M-14.04M-10.27M——
Capital Expenditures-1.92M-1.89M-1.90M-1.24M-790.00K-1.10M-332.00K-1.02M——
Investing Cash Flow21.22M-1.43M-235.44M-1.24M-790.00K-1.10M-332.00K-1.02M——
Debt Repaid——0———————
Financing Cash Flow2.05M6.16M-50.00K214.94M-1.77M72.92M851.00K983.00K——
Net Change in Cash14.69M-25.11M-246.16M210.96M-29.58M58.42M-13.29M-10.71M——
Free Cash Flow-10.50M-31.99M-12.49M-4.19M-28.09M-14.27M-14.37M-11.29M——

This table shows 10 quarterly periods of Heartflow's cash flow statement, from Q2 2026 back to Q1 2024, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HTFL's reporting calendar. What is a cash flow statement?

More financial data